世界のウルトラヌクレアーゼ市場インサイト及び予測(Cas9、Cas10、Cas12)

【英語タイトル】Global Ultra Nuclease Market Insights, Forecast to 2028

QYResearchが出版した調査資料(QY22DE19431)・商品コード:QY22DE19431
・発行会社(調査会社):QYResearch
・発行日:2022年12月
・ページ数:88
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

COVID-19パンデミックとロシア・ウクライナ戦争の影響により、ウルトラヌクレアーゼの世界市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
ウルトラヌクレアーゼのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
ウルトラヌクレアーゼの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
ウルトラヌクレアーゼのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面に関しては、当レポートは2017年から2022年までのウルトラヌクレアーゼの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面に関しては、当レポートは2017年から2022年までの地域別、企業別、種類別、用途別のウルトラヌクレアーゼの売上および2028年までの予測に焦点を当てています。

ウルトラヌクレアーゼのグローバル主要企業には、Agilent、Horizo​​n Discovery、Integrated DNA Technologies, Inc.、Thermo Fisher Scientific、GenScript、Aldevronなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ウルトラヌクレアーゼ市場は、種類と用途によって区分されます。世界のウルトラヌクレアーゼ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
Cas9、Cas10、Cas12

【用途別セグメント】
細胞/遺伝子治療、遺伝子診断、農業、バイオエネルギー、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ウルトラヌクレアーゼ製品概要
- 種類別市場(Cas9、Cas10、Cas12)
- 用途別市場(細胞/遺伝子治療、遺伝子診断、農業、バイオエネルギー、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のウルトラヌクレアーゼ販売量予測2017-2028
- 世界のウルトラヌクレアーゼ売上予測2017-2028
- ウルトラヌクレアーゼの地域別販売量
- ウルトラヌクレアーゼの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ウルトラヌクレアーゼ販売量
- 主要メーカー別ウルトラヌクレアーゼ売上
- 主要メーカー別ウルトラヌクレアーゼ価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(Cas9、Cas10、Cas12)
- ウルトラヌクレアーゼの種類別販売量
- ウルトラヌクレアーゼの種類別売上
- ウルトラヌクレアーゼの種類別価格
・用途別市場規模(細胞/遺伝子治療、遺伝子診断、農業、バイオエネルギー、その他)
- ウルトラヌクレアーゼの用途別販売量
- ウルトラヌクレアーゼの用途別売上
- ウルトラヌクレアーゼの用途別価格
・北米市場
- 北米のウルトラヌクレアーゼ市場規模(種類別、用途別)
- 主要国別のウルトラヌクレアーゼ市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのウルトラヌクレアーゼ市場規模(種類別、用途別)
- 主要国別のウルトラヌクレアーゼ市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のウルトラヌクレアーゼ市場規模(種類別、用途別)
- 主要国別のウルトラヌクレアーゼ市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のウルトラヌクレアーゼ市場規模(種類別、用途別)
- 主要国別のウルトラヌクレアーゼ市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのウルトラヌクレアーゼ市場規模(種類別、用途別)
- 主要国別のウルトラヌクレアーゼ市場規模(トルコ、サウジアラビア)
・企業情報
Agilent、Horizo​​n Discovery、Integrated DNA Technologies, Inc.、Thermo Fisher Scientific、GenScript、Aldevron
・産業チェーン及び販売チャネル分析
- ウルトラヌクレアーゼの産業チェーン分析
- ウルトラヌクレアーゼの原材料
- ウルトラヌクレアーゼの生産プロセス
- ウルトラヌクレアーゼの販売及びマーケティング
- ウルトラヌクレアーゼの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ウルトラヌクレアーゼの産業動向
- ウルトラヌクレアーゼのマーケットドライバー
- ウルトラヌクレアーゼの課題
- ウルトラヌクレアーゼの阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Ultra Nuclease estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Ultra Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Ultra Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Ultra Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Ultra Nuclease include Agilent, Horizo​​n Discovery, Integrated DNA Technologies, Inc., Thermo Fisher Scientific, GenScript and Aldevron, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Ultra Nuclease companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Ultra Nuclease market. Further, it explains the major drivers and regional dynamics of the global Ultra Nuclease market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Agilent
Horizo​​n Discovery
Integrated DNA Technologies, Inc.
Thermo Fisher Scientific
GenScript
Aldevron
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Ultra Nuclease Segment by Type
Cas9
Cas10
Cas12
Ultra Nuclease Segment by Application
Cell and Gene Therapy
Genetic Diagnosis
Agriculture
Bioenergy
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Ultra Nuclease market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Ultra Nuclease market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Ultra Nuclease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Ultra Nuclease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ultra Nuclease revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Ultra Nuclease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Ultra Nuclease revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Agilent, Horizo​​n Discovery, Integrated DNA Technologies, Inc., Thermo Fisher Scientific, GenScript and Aldevron, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Ultra Nuclease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ultra Nuclease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ultra Nuclease revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ultra Nuclease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cas9
1.2.3 Cas10
1.2.4 Cas12
1.3 Market by Application
1.3.1 Global Ultra Nuclease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cell and Gene Therapy
1.3.3 Genetic Diagnosis
1.3.4 Agriculture
1.3.5 Bioenergy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ultra Nuclease Market Perspective (2017-2028)
2.2 Ultra Nuclease Growth Trends by Region
2.2.1 Ultra Nuclease Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Ultra Nuclease Historic Market Size by Region (2017-2022)
2.2.3 Ultra Nuclease Forecasted Market Size by Region (2023-2028)
2.3 Ultra Nuclease Market Dynamics
2.3.1 Ultra Nuclease Industry Trends
2.3.2 Ultra Nuclease Market Drivers
2.3.3 Ultra Nuclease Market Challenges
2.3.4 Ultra Nuclease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ultra Nuclease Players by Revenue
3.1.1 Global Top Ultra Nuclease Players by Revenue (2017-2022)
3.1.2 Global Ultra Nuclease Revenue Market Share by Players (2017-2022)
3.2 Global Ultra Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ultra Nuclease Revenue
3.4 Global Ultra Nuclease Market Concentration Ratio
3.4.1 Global Ultra Nuclease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ultra Nuclease Revenue in 2021
3.5 Ultra Nuclease Key Players Head office and Area Served
3.6 Key Players Ultra Nuclease Product Solution and Service
3.7 Date of Enter into Ultra Nuclease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ultra Nuclease Breakdown Data by Type
4.1 Global Ultra Nuclease Historic Market Size by Type (2017-2022)
4.2 Global Ultra Nuclease Forecasted Market Size by Type (2023-2028)
5 Ultra Nuclease Breakdown Data by Application
5.1 Global Ultra Nuclease Historic Market Size by Application (2017-2022)
5.2 Global Ultra Nuclease Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Ultra Nuclease Market Size (2017-2028)
6.2 North America Ultra Nuclease Market Size by Type
6.2.1 North America Ultra Nuclease Market Size by Type (2017-2022)
6.2.2 North America Ultra Nuclease Market Size by Type (2023-2028)
6.2.3 North America Ultra Nuclease Market Share by Type (2017-2028)
6.3 North America Ultra Nuclease Market Size by Application
6.3.1 North America Ultra Nuclease Market Size by Application (2017-2022)
6.3.2 North America Ultra Nuclease Market Size by Application (2023-2028)
6.3.3 North America Ultra Nuclease Market Share by Application (2017-2028)
6.4 North America Ultra Nuclease Market Size by Country
6.4.1 North America Ultra Nuclease Market Size by Country (2017-2022)
6.4.2 North America Ultra Nuclease Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Ultra Nuclease Market Size (2017-2028)
7.2 Europe Ultra Nuclease Market Size by Type
7.2.1 Europe Ultra Nuclease Market Size by Type (2017-2022)
7.2.2 Europe Ultra Nuclease Market Size by Type (2023-2028)
7.2.3 Europe Ultra Nuclease Market Share by Type (2017-2028)
7.3 Europe Ultra Nuclease Market Size by Application
7.3.1 Europe Ultra Nuclease Market Size by Application (2017-2022)
7.3.2 Europe Ultra Nuclease Market Size by Application (2023-2028)
7.3.3 Europe Ultra Nuclease Market Share by Application (2017-2028)
7.4 Europe Ultra Nuclease Market Size by Country
7.4.1 Europe Ultra Nuclease Market Size by Country (2017-2022)
7.4.2 Europe Ultra Nuclease Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ultra Nuclease Market Size (2017-2028)
8.2 Asia-Pacific Ultra Nuclease Market Size by Type
8.2.1 Asia-Pacific Ultra Nuclease Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Ultra Nuclease Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Ultra Nuclease Market Share by Type (2017-2028)
8.3 Asia-Pacific Ultra Nuclease Market Size by Application
8.3.1 Asia-Pacific Ultra Nuclease Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Ultra Nuclease Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Ultra Nuclease Market Share by Application (2017-2028)
8.4 Asia-Pacific Ultra Nuclease Market Size by Region
8.4.1 Asia-Pacific Ultra Nuclease Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Ultra Nuclease Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ultra Nuclease Market Size (2017-2028)
9.2 Latin America Ultra Nuclease Market Size by Type
9.2.1 Latin America Ultra Nuclease Market Size by Type (2017-2022)
9.2.2 Latin America Ultra Nuclease Market Size by Type (2023-2028)
9.2.3 Latin America Ultra Nuclease Market Share by Type (2017-2028)
9.3 Latin America Ultra Nuclease Market Size by Application
9.3.1 Latin America Ultra Nuclease Market Size by Application (2017-2022)
9.3.2 Latin America Ultra Nuclease Market Size by Application (2023-2028)
9.3.3 Latin America Ultra Nuclease Market Share by Application (2017-2028)
9.4 Latin America Ultra Nuclease Market Size by Country
9.4.1 Latin America Ultra Nuclease Market Size by Country (2017-2022)
9.4.2 Latin America Ultra Nuclease Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ultra Nuclease Market Size (2017-2028)
10.2 Middle East & Africa Ultra Nuclease Market Size by Type
10.2.1 Middle East & Africa Ultra Nuclease Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Ultra Nuclease Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Ultra Nuclease Market Share by Type (2017-2028)
10.3 Middle East & Africa Ultra Nuclease Market Size by Application
10.3.1 Middle East & Africa Ultra Nuclease Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Ultra Nuclease Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Ultra Nuclease Market Share by Application (2017-2028)
10.4 Middle East & Africa Ultra Nuclease Market Size by Country
10.4.1 Middle East & Africa Ultra Nuclease Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Ultra Nuclease Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Details
11.1.2 Agilent Business Overview
11.1.3 Agilent Ultra Nuclease Introduction
11.1.4 Agilent Revenue in Ultra Nuclease Business (2017-2022)
11.1.5 Agilent Recent Developments
11.2 Horizo​​n Discovery
11.2.1 Horizo​​n Discovery Company Details
11.2.2 Horizo​​n Discovery Business Overview
11.2.3 Horizo​​n Discovery Ultra Nuclease Introduction
11.2.4 Horizo​​n Discovery Revenue in Ultra Nuclease Business (2017-2022)
11.2.5 Horizo​​n Discovery Recent Developments
11.3 Integrated DNA Technologies, Inc.
11.3.1 Integrated DNA Technologies, Inc. Company Details
11.3.2 Integrated DNA Technologies, Inc. Business Overview
11.3.3 Integrated DNA Technologies, Inc. Ultra Nuclease Introduction
11.3.4 Integrated DNA Technologies, Inc. Revenue in Ultra Nuclease Business (2017-2022)
11.3.5 Integrated DNA Technologies, Inc. Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Ultra Nuclease Introduction
11.4.4 Thermo Fisher Scientific Revenue in Ultra Nuclease Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 GenScript
11.5.1 GenScript Company Details
11.5.2 GenScript Business Overview
11.5.3 GenScript Ultra Nuclease Introduction
11.5.4 GenScript Revenue in Ultra Nuclease Business (2017-2022)
11.5.5 GenScript Recent Developments
11.6 Aldevron
11.6.1 Aldevron Company Details
11.6.2 Aldevron Business Overview
11.6.3 Aldevron Ultra Nuclease Introduction
11.6.4 Aldevron Revenue in Ultra Nuclease Business (2017-2022)
11.6.5 Aldevron Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Ultra Nuclease Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Cas9
Table 3. Key Players of Cas10
Table 4. Key Players of Cas12
Table 5. Global Ultra Nuclease Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Ultra Nuclease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Ultra Nuclease Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Ultra Nuclease Market Share by Region (2017-2022)
Table 9. Global Ultra Nuclease Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Ultra Nuclease Market Share by Region (2023-2028)
Table 11. Ultra Nuclease Market Trends
Table 12. Ultra Nuclease Market Drivers
Table 13. Ultra Nuclease Market Challenges
Table 14. Ultra Nuclease Market Restraints
Table 15. Global Ultra Nuclease Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Ultra Nuclease Revenue Share by Players (2017-2022)
Table 17. Global Top Ultra Nuclease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultra Nuclease as of 2021)
Table 18. Ranking of Global Top Ultra Nuclease Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Ultra Nuclease Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ultra Nuclease Product Solution and Service
Table 22. Date of Enter into Ultra Nuclease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ultra Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Ultra Nuclease Revenue Market Share by Type (2017-2022)
Table 26. Global Ultra Nuclease Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Ultra Nuclease Revenue Market Share by Type (2023-2028)
Table 28. Global Ultra Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Ultra Nuclease Revenue Share by Application (2017-2022)
Table 30. Global Ultra Nuclease Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Ultra Nuclease Revenue Share by Application (2023-2028)
Table 32. North America Ultra Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Ultra Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Ultra Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Ultra Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Ultra Nuclease Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Ultra Nuclease Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Ultra Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Ultra Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Ultra Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Ultra Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Ultra Nuclease Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Ultra Nuclease Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Ultra Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Ultra Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Ultra Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Ultra Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Ultra Nuclease Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Ultra Nuclease Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Ultra Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Ultra Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Ultra Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Ultra Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Ultra Nuclease Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Ultra Nuclease Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Ultra Nuclease Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Ultra Nuclease Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Ultra Nuclease Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Ultra Nuclease Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Ultra Nuclease Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Ultra Nuclease Market Size by Country (2023-2028) & (US$ Million)
Table 62. Agilent Company Details
Table 63. Agilent Business Overview
Table 64. Agilent Ultra Nuclease Product
Table 65. Agilent Revenue in Ultra Nuclease Business (2017-2022) & (US$ Million)
Table 66. Agilent Recent Developments
Table 67. Horizo​​n Discovery Company Details
Table 68. Horizo​​n Discovery Business Overview
Table 69. Horizo​​n Discovery Ultra Nuclease Product
Table 70. Horizo​​n Discovery Revenue in Ultra Nuclease Business (2017-2022) & (US$ Million)
Table 71. Horizo​​n Discovery Recent Developments
Table 72. Integrated DNA Technologies, Inc. Company Details
Table 73. Integrated DNA Technologies, Inc. Business Overview
Table 74. Integrated DNA Technologies, Inc. Ultra Nuclease Product
Table 75. Integrated DNA Technologies, Inc. Revenue in Ultra Nuclease Business (2017-2022) & (US$ Million)
Table 76. Integrated DNA Technologies, Inc. Recent Developments
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Ultra Nuclease Product
Table 80. Thermo Fisher Scientific Revenue in Ultra Nuclease Business (2017-2022) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Developments
Table 82. GenScript Company Details
Table 83. GenScript Business Overview
Table 84. GenScript Ultra Nuclease Product
Table 85. GenScript Revenue in Ultra Nuclease Business (2017-2022) & (US$ Million)
Table 86. GenScript Recent Developments
Table 87. Aldevron Company Details
Table 88. Aldevron Business Overview
Table 89. Aldevron Ultra Nuclease Product
Table 90. Aldevron Revenue in Ultra Nuclease Business (2017-2022) & (US$ Million)
Table 91. Aldevron Recent Developments
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ultra Nuclease Market Share by Type: 2021 VS 2028
Figure 2. Cas9 Features
Figure 3. Cas10 Features
Figure 4. Cas12 Features
Figure 5. Global Ultra Nuclease Market Share by Application: 2021 VS 2028
Figure 6. Cell and Gene Therapy Case Studies
Figure 7. Genetic Diagnosis Case Studies
Figure 8. Agriculture Case Studies
Figure 9. Bioenergy Case Studies
Figure 10. Others Case Studies
Figure 11. Ultra Nuclease Report Years Considered
Figure 12. Global Ultra Nuclease Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Ultra Nuclease Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Ultra Nuclease Market Share by Region: 2021 VS 2028
Figure 15. Global Ultra Nuclease Market Share by Players in 2021
Figure 16. Global Top Ultra Nuclease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultra Nuclease as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Ultra Nuclease Revenue in 2021
Figure 18. North America Ultra Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Ultra Nuclease Market Size Market Share by Type (2017-2028)
Figure 20. North America Ultra Nuclease Market Size Market Share by Application (2017-2028)
Figure 21. North America Ultra Nuclease Market Size Share by Country (2017-2028)
Figure 22. United States Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Ultra Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Ultra Nuclease Market Size Market Share by Type (2017-2028)
Figure 26. Europe Ultra Nuclease Market Size Market Share by Application (2017-2028)
Figure 27. Europe Ultra Nuclease Market Size Share by Country (2017-2028)
Figure 28. Germany Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Ultra Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Ultra Nuclease Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Ultra Nuclease Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Ultra Nuclease Market Size Share by Region (2017-2028)
Figure 38. China Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Ultra Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Ultra Nuclease Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Ultra Nuclease Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Ultra Nuclease Market Size Share by Country (2017-2028)
Figure 48. Mexico Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Ultra Nuclease Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Ultra Nuclease Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Ultra Nuclease Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Ultra Nuclease Market Size Share by Country (2017-2028)
Figure 54. Turkey Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Ultra Nuclease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Agilent Revenue Growth Rate in Ultra Nuclease Business (2017-2022)
Figure 58. Horizo​​n Discovery Revenue Growth Rate in Ultra Nuclease Business (2017-2022)
Figure 59. Integrated DNA Technologies, Inc. Revenue Growth Rate in Ultra Nuclease Business (2017-2022)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Ultra Nuclease Business (2017-2022)
Figure 61. GenScript Revenue Growth Rate in Ultra Nuclease Business (2017-2022)
Figure 62. Aldevron Revenue Growth Rate in Ultra Nuclease Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


★調査レポート[世界のウルトラヌクレアーゼ市場インサイト及び予測(Cas9、Cas10、Cas12)] (コード:QY22DE19431)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のウルトラヌクレアーゼ市場インサイト及び予測(Cas9、Cas10、Cas12)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆